| Similar Articles |
|---|
 |
Salon.com
June 1, 2001
Daryl Lindsey |
The AIDS-drug warrior Outspoken AIDS-drug activist Jamie Love says pharmaceutical companies must be forced to yield their patents to save hundreds of thousands of lives. Is he a visionary -- or a dangerous radical?   |
Salon.com
March 19, 2001
Ben Barber |
Fighting the plague The World Trade Organization steps into Africa's AIDS crisis, creating incentives for pharmaceutical companies to give some of their drugs away. |
Salon.com
June 25, 2001
Daryl Lindsey |
AIDS activists change their act On the eve of a United Nations conference, the once-militant ACT-UP revises its tactics and focus... |
The Motley Fool
December 14, 2006
Stephen Albainy-Jenei |
Merck Gets Punk'd by Thailand Thailand issues a compulsory license to manufacture a generic version of Merck's patented AIDS drug. This is an act of humanitarian aid, but it is also an avenue for price and profit erosion worldwide. |
BusinessWeek
August 5, 2010
Bennett & Randall |
AIDS Drugs Flow to the Third World Drugmakers, once blasted for their practices, are slashing prices and licensing AIDS drugs for free to nonprofits or local manufacturers in developing countries. |
Salon.com
May 18, 2000
Sabin Russell |
The dream and the coming disaster AIDS threatens to ravage the hopes of South Africa's young democracy. Don't expect leaders to get excited because a few companies cut the cost of HIV drugs. |
Salon.com
June 27, 2001
Daryl Lindsey |
A pandemic fueled by poverty A doctor says the fight to get cheap AIDS drugs to Africa is misguided: These people need water, food and basic healthcare... |
Reason
February 2002
Mike Godwin |
Prescription Panic How the anthrax scare challenged drug patents... |
The Motley Fool
March 14, 2008
Stephen Albainy-Jenei |
The War on (the Cost of) Drugs Pharmaceutical companies could be hurt by countries disregarding drug patents. |
Wired
December 2006
Erika Check |
The Treasure of Mumbai In the pharmaceutical industry, Indian drugmaker Cipla is a pirate operation. To the developing world, it's a vital medicine chest. And now its cheap pills are coming to a pharmacy near you. |
Pharmaceutical Executive
October 1, 2011
Amrita Ghaswalla |
Changing the Dialogue No industry leader is more closely associated with the goal of seeding the globe with low-cost generics than Mumbai-based Cipla Chairman Y.K. Hamied. |
Pharmaceutical Executive
May 1, 2012 |
Country Report: South Africa In just the past few years, South Africa has hit several key economic benchmarks demonstrating the country's upward trajectory. |
Pharmaceutical Executive
October 1, 2005
Jill Wechsler |
Washington Report: Antivirals: Meeting a World of Need The international fight against AIDS requires drugs -- and policy. |
Salon.com
July 28, 2000
Kate Scanell |
Contributing to genocide By giving HIV deniers a global platform, South African President Mbeki has put countless lives at risk. |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists. |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
Salon.com
August 22, 2001
Michael McColly |
Whisper of death Poverty, a rigid class system and conservative Hindu values are quickly turning India into the next South Africa in the global AIDS pandemic... |
Chemistry World
May 15, 2015
Rebecca Trager |
Trade agreement could limit access to medicines A leaked draft of a trade agreement under negotiation among 12 Pacific rim countries, including the US and Japan, contains language that could delay the entrance of generic competition for much-needed medicines. |
CFO
Kris Frieswick |
Clinical Trials A new kind of pricing pressure puts pharmaceutical CFOs in an unfamiliar role: evangelist... |
Chemistry World
July 11, 2012
Ling Wang |
China Targets Patented Drugs with Law Change China has altered its licensing laws to allow domestic pharmaceutical companies to make cheap generic copies of patented drugs under certain circumstances. |
Salon.com
February 4, 2000
Emily Bass |
A new urgency With his country at the epicenter of an AIDS epidemic, the special advisor to South Africa's health minister quietly makes his first trip to an important research conference. |
The Motley Fool
January 31, 2007
Brian Lawler |
You're Only Hurting Yourself, Thailand Thailand's decision to allow generics could do more harm than good. Investors, take note. |
Salon.com
May 28, 2001
Ben Barber |
Tough love for Africa Colin Powell gets a hero's welcome and tells Africa's entrenched rulers to step aside... |
BusinessWeek
April 18, 2005
Manjeet Kripalani |
India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India. |
Chemistry World
October 29, 2007
Arthur Rogers |
Deal to Allow Poor Nations Better Access to Cheap Drugs MEPs belatedly approved EU ratification of a 2005 World Trade Organization protocol on compulsory licensing -- potentially paving the way for developing countries to order generic drugs from manufacturers abroad without infringing patent rights. |
Salon.com
July 13, 2000
Megan Williams |
African mothers: Save us, too AIDS activists say providing drugs to prevent HIV transmission to babies but not treating their mothers is unconscionable. |
Chemistry World
August 23, 2012
Dean Baker |
Monopoly money It is remarkable that the system of patent support for prescription drug research has not become more of a policy issue. |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
Chemistry World
September 17, 2010
Andrew Turley |
Free trade could throttle generics from India International agreements on intellectual property threaten the flow of generic HIV drugs from India to developing countries, according to a new report. |
Pharmaceutical Executive
September 1, 2006
Kieran Hartsough |
Benchmarking AIDS Pharma is taking on the global AIDS crisis. But who has crafted the best approach? The Interfaith Center on Corporate Responsibility defines best practices and matches major companies head-to-head. Grades are posted inside. |
Chemistry World
February 15, 2007
Victoria Gill |
Novartis Contests India's Patent Law Swiss pharmaceutical company Novartis has accused the Indian government of failing to comply with WTO rules after it refused to grant the company a patent on its cancer drug Glivec. |
Chemistry World
March 27, 2013
Eugene Gerden |
Russian investment vehicle sets sights on innovative drugs Russian state-owned nanotechnology giant Rusnano is hoping to break into the pharmaceutical sector with sizeable investments in firms seeking to produce innovative drugs. |
Salon.com
June 28, 2001
Daryl Lindsey |
U.N. commits to AIDS reduction Its far-reaching declaration could funnel billions toward reducing the spread of the disease by 25 percent... |
Pharmaceutical Executive
December 1, 2010
Zhu Shen |
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda |
Reason
October 2007
Ronald Bailey |
Is Industry-Funded Science Killing You? The overrated risks and underrated benefits of pharmaceutical research "conflicts of interest." |
BusinessWeek
August 2, 2004
Arnst & Einhorn |
Why Business Should Make AIDS Its Business Some multinational companies are taking baby steps to control the AIDS in their workforce, but more needs to be done. |
Pharmaceutical Executive
September 1, 2013
William Looney |
High Noon For Hot Markets Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets. |
Pharmaceutical Executive
July 30, 2007
Walter Armstrong |
Tibotec Gets AIDS With a new wave of "resistant to resistance" HIV drugs, a record of consistent innovation, and a dynamic partnership with AIDS activists, Tibotec is in it to win it. And end it. |
The Motley Fool
March 20, 2007
Brian Lawler |
Smart Move by Abbott? Abbott takes a drastic measure to make a point about its patents. Thailand's actions offer a good warning of what can happen when governments try to intervene too much in existing markets. |
Chemistry World
January 21, 2013
Andy Extance |
India pushes for emergency drug licenses The Indian government is preparing to grant compulsory licenses allowing three patented cancer drugs to be produced in the country and sold at reduced rates without permission from the patent owners. |
Salon.com
July 12, 2001
Daryl Lindsey |
Woe is me-zine After bemoaning attacks from the "far left," Andrew Sullivan returns a sponsorship from the pharmaceutical industry... |
Salon.com
December 1, 2000
Fiona Morgan |
It's World AIDS Day ... again Americans with insurance now improve with new drugs, but the disease is on a rampage across the rest of the world... |
Salon.com
June 26, 2001
Daryl Lindsey |
AIDS conclave off to rocky start A gay rights group gets included in the end, but members split over whether -- and how -- to talk about homosexuality when crafting a response to the disease... |
Managed Care
September 2006 |
Payers, Consumers Benefit as Patents Expire The generic drug market seems ready to explode, according to reports from IMS Health and the Generic Pharmaceuticals Association. |
IDB America
September 2001
Charo Quesada |
The cost of silence The executive director of UNAIDS urges Latin America and the Caribbean to break the silence surrounding AIDS if they wish to avert greater tragedy... |
Pharmaceutical Executive
September 1, 2012
Stan Bernard |
The Payer C Change: From Customers to Competitors "Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets." Understanding why and how this payer shift to dominance occurred is critical for pharmaceutical professionals in adjusting their business model. |
Salon.com
June 26, 2001
Daryl Lindsey |
Caught in the act Activist groups are kicked out of U.N. headquarters in a protest at the global AIDS conference... |
The Motley Fool
January 26, 2009
Brian Orelli |
Have Drugs, Will Travel After buying Bristol-Myers Squibb's businesses in Egypt and Pakistan, GlaxoSmithKline is now off to Africa. |
The Motley Fool
April 26, 2007
Brian Lawler |
Brazil's Boneheaded Drug Move Brazil already receives a steep discount on the price that Merck charges it for its HIV compounds. Nevertheless, it wants still lower prices to help reduce the government's costs associated with supplying drugs to those living with HIV/AIDS. |
Salon.com
October 18, 2001
Anthony York |
Is it time to bust the Cipro patent? Activist Jamie Love accuses the Bush administration of putting corporate profits above public safety... |
